Gynecologic Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gynecologic oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gynecologic Oncology Today - Breaking & Trending Today

Culture of Sexual Harassment, Bullying Plagues Ob.Gyn.

The primary perpetrators of unwanted behaviors were overwhelmingly attending physicians, although residents and fellows were also identified as perpetrators, a new study found. ....

University Of Louisville , United States , Ankita Gupta , Society Of Gynecologic Oncology , Society Of Gynecologic Surgeons , Gynecologic Surgeons , Gynecologic Oncology ,

Overcoming Adversity and Achieving the American Dream in Cancer Care

From barely escaping a life under communism in a Russia-occupied Latvia to overcoming a family health crisis, Robert F. Ozols, MD, PhD, knows a thing or two about beating the odds. ....

Fox Chase , United States , Fox Chase Cancer Center , United Kingdom , City Of , University Of Rochester , New York , Justice Warrene Burger , Robert Bobc Young , Lawrenceh Einhorn , Thomas Hamilton , Robertf Ozols , Bob Young , American Society Of Clinical Investigation , Medicine Branch Of The National Cancer Institute , Medicine Branch , Public Health Service , National Cancer Institute , International Gynecologic Cancer Society Award For Excellence , Red Army , Us Public Health Service , Dartmouth Medical School , Indiana University School Of Medicine , Gynecologic Oncology Group , Cancer Care , Fox Chase Cancer ,

Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of. ....

United States , Philippe Dubuc , Julie Schneiderman , Ira Winer , Theratechnologie Sudocetaxel Zendusortide , Christian Marsolais , American Society Of Clinical Oncology , Professor Of Oncology At Wayne State University , Theratechnologies Inc , Communications Corporate Affairs , Demonstrates Signs , Long Term Efficacy , Manageable Safety Profile , Clinical Oncology , Response Evaluation Criteria , Solid Tumors , Gynecologic Oncology , Trials Multidisciplinary Teams , Karmanos Cancer Center , Associate Professor , Wayne State , Senior Vice President , Chief Medical Officer , Sudocetaxel Zendusortide , Fast Track , Forward Looking Statements ,

Jill Kolesar named next College of Pharmacy dean

Jill M. Kolesar, university research professor in the University of Kentucky College of Pharmacy and the Dr. Michael Karpf Endowed Chair in Precision Medicine, has been named dean of the University of Iowa College of Pharmacy. She will begin on July 15. ....

University Of Texas , United States , San Antonio , Clark Stanford , Nicole Brogden , Don Letendre , Kevin Kregel , Jillm Kolesar , University Of Iowa , University Of Kentucky College Medicine , University Of Texas Health Science Center , University Of Kentucky College Pharmacy , Division Of Gynecologic Oncology , Translational Oncology Program , Madison School Of Pharmacy , University Of Kentucky , American Cancer Society , University Of Iowa College Pharmacy , Public Health , College Of Pharmacy , National Cancer Institute , University Of Wisconsin School Medicine , College Of Dentistry , Markey Cancer Center , University Of Wisconsin , Kentucky College ,

Exploiting the Vulnerabilities of High-Grade Serous Ovarian Cancer Through WEE1 Inhibition

Joyce F. Liu, MD, MPH, provides insights on WEE1 which has emerged as a potentially targetable pathway in high-grade serous ovarian cancer. ....

United States , Dana Farber Cancer Institute , Sri Lanka , Joycef Liu , End Results Program , Zentalis Pharmaceuticals , Women Health , Harvard Medical School , Division Of Gynecologic Oncology , American Society Of Clinical Oncology Annual Meeting , National Cancer Institute Surveillance , Gynecologic Oncology , Displays Preliminary Efficacy , Clinical Oncology Annual Meeting , Gynecologic Oncology Annual Meeting , Cancer Institute Surveillance , End Results , Accessed May , Intj Mol ,